-
1
-
-
2442489811
-
The epidemiology of hepatitis C virus infection. An update for clinicians
-
Pellicano R, Mladenova I, Dimitrova M, Bruno CM, Sciacca C, Rizzetto M. The epidemiology of hepatitis C virus infection. An update for clinicians. Minerva Gastroenterol Dietol 2004;50:1-7.
-
(2004)
Minerva Gastroenterol Dietol
, vol.50
, pp. 1-7
-
-
Pellicano, R.1
Mladenova, I.2
Dimitrova, M.3
Bruno, C.M.4
Sciacca, C.5
Rizzetto, M.6
-
2
-
-
3543098600
-
Liver fibrosis: From the bench to clinical targets
-
DOI 10.1016/j.dld.2004.01.003
-
Pinzani M, Rombouts K. Liver fibrosis: from the bench to clinical targets. Dig Liver Dis 2004;36:231-242 (Pubitemid 41115470)
-
(2004)
Digestive and Liver Disease
, vol.36
, Issue.4
, pp. 231-242
-
-
Pinzani, M.1
Rombouts, K.2
-
5
-
-
43049138463
-
Inflammation and repair in viral hepatitis C
-
Neuman MG, Sha K, Esguerra R, Zakhari S, Winkler RE, Hilzenrat N et al. Inflammation and repair in viral hepatitis C. Dig Dis Sci 2008;53:1468-1487
-
(2008)
Dig Dis Sci
, vol.53
, pp. 1468-1487
-
-
Neuman, M.G.1
Sha, K.2
Esguerra, R.3
Zakhari, S.4
Winkler, R.E.5
Hilzenrat, N.6
-
6
-
-
0030093706
-
Collagenases and tissue inhibitors of metalloproteinases: A functional balance in tissue degradation
-
Reynolds JJ. Collagenases and tissue inhibitors of metalloproteinases: a functional balance in tissue degradation. Oral Dis 1996;2:70-76
-
(1996)
Oral Dis
, vol.2
, pp. 70-76
-
-
Reynolds, J.J.1
-
7
-
-
31744445961
-
Matrix metalloproteinases (MMPs) in health and disease: An overview
-
Malemud CJ. Matrix metalloproteinases (MMPs) in health and disease: an overview. Front Biosci 2006;11:1696-1701
-
(2006)
Front Biosci
, vol.11
, pp. 1696-1701
-
-
Malemud, C.J.1
-
8
-
-
0033618337
-
Waessner JE Matrix metalloproteinases
-
Nagase H, Waessner JE Matrix metalloproteinases. J Biol Chem 1999;274:21491-21494
-
(1999)
J Biol Chem
, vol.274
, pp. 21491-21494
-
-
Nagase, H.1
-
9
-
-
0037693895
-
Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function and biochemistry
-
Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function and biochemistry. Circ Res 2003;92:827-839
-
(2003)
Circ Res
, vol.92
, pp. 827-839
-
-
Visse, R.1
Nagase, H.2
-
10
-
-
31344458952
-
Structure and function of matrix metalloproteinases and TIMPs
-
DOI 10.1016/j.cardiores.2005.12.002, PII S0008636305005651
-
Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 2006;69:562-573 (Pubitemid 43139720)
-
(2006)
Cardiovascular Research
, vol.69
, Issue.3
, pp. 562-573
-
-
Nagase, H.1
Visse, R.2
Murphy, G.3
-
11
-
-
20644465610
-
Progelatinase A is produced and activated by rat hepatic stellate cells and promotes their proliferation
-
DOI 10.1002/hep.510300431
-
Benyon RC, Hovell CJ, Da Gaca M, Jones EH, Iredale JP, Arthur MJ. Progelatinase A is produced and activated by rat hepatic stellate cells and promotes their proliferation. Hepatology 1999;30:977-986 (Pubitemid 29458287)
-
(1999)
Hepatology
, vol.30
, Issue.4
, pp. 977-986
-
-
Benyon, R.C.1
Hovell, C.J.2
Da Gaca, M.3
Jones, E.H.4
Iredale, J.P.5
Arthur, M.J.6
-
12
-
-
0032952079
-
Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: Regulation by TNF-α and TGF-β1
-
DOI 10.1016/S0168-8278(99)80007-5
-
Knittel T, Mehde M, Kobold D, Saile B, Dimer C, Ramadori G. Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: regulation by TNF-alpha and TGF-betal. J Hepatol 1999;30:48-60. (Pubitemid 29023652)
-
(1999)
Journal of Hepatology
, vol.30
, Issue.1
, pp. 48-60
-
-
Knittel, T.1
Mehde, M.2
Kobold, D.3
Saile, B.4
Dinter, C.5
Ramadori, G.6
-
13
-
-
0030030039
-
Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver
-
DOI 10.1053/gast.1996.v110.pm8608892
-
Benyon RC, Iredale JP, Goddard S, Winwood PJ, Arthur MJ. Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver. Gastroenterology 1996;110:821-831 (Pubitemid 26071850)
-
(1996)
Gastroenterology
, vol.110
, Issue.3
, pp. 821-831
-
-
Benyon, R.C.1
Iredale, J.P.2
Goddard, S.3
Winwood, P.J.4
Arthur, M.J.5
-
14
-
-
0031740778
-
Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis
-
Kossakowska AE, Edwards DR, Lee SS, Urbanski LS, Stabbler AL, Zhang CC et al. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis. Am J Pathol 1998;153:1895-1902
-
(1998)
Am J Pathol
, vol.153
, pp. 1895-1902
-
-
Kossakowska, A.E.1
Edwards, D.R.2
Lee, S.S.3
Urbanski, L.S.4
Stabbler, A.L.5
Zhang, C.C.6
-
15
-
-
0034856294
-
Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver
-
Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001;35:421-430
-
(2001)
J Hepatol
, vol.35
, pp. 421-430
-
-
Bruix, J.1
Sherman, M.2
Llovet, J.M.3
Beaugrand, M.4
Lencioni, R.5
Burroughs, A.K.6
-
16
-
-
1242307263
-
The Barcelona approach: Diagnosis, staging and treatment of hepatocellular carcinoma
-
Llovet JM, Fuster J, Bruix J. The Barcelona approach: diagnosis, staging and treatment of hepatocellular carcinoma. Liver Transpl 2004;10:S115-120.
-
(2004)
Liver Transpl
, vol.10
-
-
Llovet, J.M.1
Fuster, J.2
Bruix, J.3
-
17
-
-
57349187662
-
A study about mechanisms of des-gamma-carboxy prothrombin's production in hepatocellular carcinoma
-
Bertino G, Ardiri AM, Boemi PM, lerna D, Interlandi D, Caruso L et al. A study about mechanisms of des-gamma-carboxy prothrombin's production in hepatocellular carcinoma. Panminerva Med 2008;50:221 6.
-
(2008)
Panminerva Med
, vol.50
, Issue.221
, pp. 6
-
-
Bertino, G.1
Ardiri, A.M.2
Boemi, P.M.3
Lerna, D.4
Interlandi, D.5
Caruso, L.6
-
18
-
-
0033557988
-
Measurement of serum levels of des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma by a revised enzyme immunoassay kit with increased sensitivity
-
Okuda H, Nakanishi T, Takatsu K, Saito A, Hayashi N, Watanabe K et al. Measurement of serum levels of des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma by a revised enzyme immunoassay kit with increased sensitivity. Cancer 1999;85:8128.
-
(1999)
Cancer
, vol.85
, pp. 8128
-
-
Okuda, H.1
Nakanishi, T.2
Takatsu, K.3
Saito, A.4
Hayashi, N.5
Watanabe, K.6
-
19
-
-
0033048769
-
Serum des-gamma-carboxy prothrombin levels determined by a new generation of sensitive immunoassays in patients with small-sized hepatocellular carcinoma
-
DOI 10.1016/S0002-9270(98)00811-9, PII S0002927098008119
-
Nomura F, Ishijima M, Kuwa K, Tanaka N, Nakai T, Ohnishi K. Serum des-gamma-carboxy prothrombin levels determined by a new generation of sensitive immunoassays in patients with small-sized hepatocellular carcinoma. Am J Gastroenterol 1999;94:650-654 (Pubitemid 29124861)
-
(1999)
American Journal of Gastroenterology
, vol.94
, Issue.3
, pp. 650-654
-
-
Nomura, F.1
Ishijima, M.2
Kuwa, K.3
Tanaka, N.4
Nakai, T.5
Ohnishi, K.6
-
20
-
-
0029039362
-
Histological grading and staging of chronic hepatitis
-
Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-699
-
(1995)
J Hepatol
, vol.22
, pp. 696-699
-
-
Ishak, K.1
Baptista, A.2
Bianchi, L.3
Callea, F.4
De Groote, J.5
Gudat, F.6
-
21
-
-
0022647490
-
Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies
-
Piccinino F, Sagnelli E, Pasquale G, Giusti G. Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J Hepatol 1986;2:165-173 (Pubitemid 16125908)
-
(1986)
Journal of Hepatology
, vol.2
, Issue.2
, pp. 165-173
-
-
Piccinino, F.1
Sagnelli, E.2
Pasquale, G.3
-
22
-
-
0037809517
-
Sampling variability on percutaneous liver biopsy in patients with chronic hepatitis C virus infection
-
DOI 10.1080/00365520310000825
-
Siddique I, El-Naga HA, Madda JP, Memon A, Hasan F. Sampling variability on percutaneous liver biopsy in patients with chronic hepatitis C virus infection. Scand J Gastroenterol 2003;38:427-432 (Pubitemid 36606313)
-
(2003)
Scandinavian Journal of Gastroenterology
, vol.38
, Issue.4
, pp. 427-432
-
-
Siddique, I.1
El-Naga, H.A.2
Madda, J.P.3
Memon, A.4
Hasan, F.5
-
23
-
-
33846846344
-
Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B
-
Sebastiani G, Vario A, Guido M, Alberti A. Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B. World J Gastroenterol 2007;13:52531.
-
(2007)
World J Gastroenterol
, vol.13
, pp. 52531
-
-
Sebastiani, G.1
Vario, A.2
Guido, M.3
Alberti, A.4
-
24
-
-
44849126116
-
Retrospective evaluation of serum markers APRI and AST/ALT for assessing liver fibrosis and cirrhosis in chronic hepatitis B and C patients with hepatocellular carcinoma
-
Lin CS, Chang CS, Yang SS, Yeh HZ, Lin CW. Retrospective evaluation of serum markers APRI and AST/ALT for assessing liver fibrosis and cirrhosis in chronic hepatitis B and C patients with hepatocellular carcinoma. Inter Med 2008;47:569-575
-
(2008)
Inter Med
, vol.47
, pp. 569-575
-
-
Lin, C.S.1
Chang, C.S.2
Yang, S.S.3
Yeh, H.Z.4
Lin, C.W.5
-
25
-
-
33644901827
-
Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C
-
Sebastiani G, Vario A, Guido M, Noventa F, Plebani M, Pistis R et al. Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C. J Hepatol 2006;44:68693.
-
(2006)
J Hepatol
, vol.44
, pp. 68693
-
-
Sebastiani, G.1
Vario, A.2
Guido, M.3
Noventa, F.4
Plebani, M.5
Pistis, R.6
-
26
-
-
0042265556
-
A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C
-
Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003;38:518-526
-
(2003)
Hepatology
, vol.38
, pp. 518-526
-
-
Wai, C.T.1
Greenson, J.K.2
Fontana, R.J.3
Kalbfleisch, J.D.4
Marrero, J.A.5
Conjeevaram, H.S.6
-
27
-
-
63549099586
-
Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis
-
Castera L. Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis. J Viral Hepat 2009;16:300-314
-
(2009)
J Viral Hepat
, vol.16
, pp. 300-314
-
-
Castera, L.1
-
28
-
-
41349094999
-
Performance of transient elastography for the staging of liver fibrosis: A meta-analysis
-
Friedrich-RustM, Ong MF, Martens S, Sarrazin C, Bojunga J, Zenzen S et al Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 2008;134:960-974
-
(2008)
Gastroenterology
, vol.134
, pp. 960-974
-
-
Friedrich-Rust, M.1
Ong, M.F.2
Martens, S.3
Sarrazin, C.4
Bojunga, J.5
Zenzen, S.6
-
29
-
-
58149461835
-
Interpreting liver stiffnes in the cirrhotic range: What are we measuring?
-
Castera L, Foras X, Alberti A. Interpreting liver stiffnes in the cirrhotic range: what are we measuring? J Hepatol 2009;50:424-425
-
(2009)
J Hepatol
, vol.50
, pp. 424-425
-
-
Castera, L.1
Foras, X.2
Alberti, A.3
-
30
-
-
0030724689
-
Dual expression of matrix metalloproteinase-2 and membrane-type 1- Matrix metalloproteinase in fibrotic human livers
-
Takahara T, Furui K, Yata Y, Jin B, Zhang LP, Nambu S et al. Dual expression of matrix metalloproteinase-2 and membrane-type 1matrix metalloproteinase in fibrotic human livers. Hepatology 1997;26:1521-1529 (Pubitemid 27520018)
-
(1997)
Hepatology
, vol.26
, Issue.6
, pp. 1521-1529
-
-
Takahara, T.1
Furui, K.2
Yata, Y.3
Jin, B.4
Zhang, L.P.5
Nambu, S.6
Sato, H.7
Seiki, M.8
Watanabe, A.9
-
31
-
-
0028906431
-
Increased expression of matrix metalloproteinase-fl in experimental liver fibrosis in rats
-
Takahara T, Furui K, Funaki J, Nakayania Y, Itoh H, Miyabayashi C et al. Increased expression of matrix metalloproteinase-fl in experimental liver fibrosis in rats. Hepatology 1995;21:787-795
-
(1995)
Hepatology
, vol.21
, pp. 787-795
-
-
Takahara, T.1
Furui, K.2
Funaki, J.3
Nakayania, Y.4
Itoh, H.5
Miyabayashi, C.6
-
32
-
-
0031942036
-
Comparison of matrix metalloproteinase expression in normal and cirrhotic human liver
-
Lichtinghagen R, Breitenstein K, Arndt B, Kuhbacher T, Boker KH. Comparison of matrix metalloproteinase expression in normal and cirrhotic human liver. Virchows Arch 1998;432:153-158
-
(1998)
Virchows Arch
, vol.432
, pp. 153-158
-
-
Lichtinghagen, R.1
Breitenstein, K.2
Arndt, B.3
Kuhbacher, T.4
Boker, K.H.5
-
33
-
-
1442301501
-
Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-I and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: Comparison with PIIINP and hyaluronic acid
-
Leroy V, Monier F, Bottari S, Trocme C, Sturm N, Hilleret MN et al. Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-I and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: comparison with PIIINP and hyaluronic acid. Am J Gastroenterol 2004;99:271-279
-
(2004)
Am J Gastroenterol
, vol.99
, pp. 271-279
-
-
Leroy, V.1
Monier, F.2
Bottari, S.3
Trocme, C.4
Sturm, N.5
Hilleret, M.N.6
-
34
-
-
0033020765
-
Plasma levels of matrix metalloproteinase-2 (MMP2) and tissue inhibitors of metalloproteinases -1 and -2 (TIMP-I and TIMP-2) as noninvasive markers of liver disease in chronic hepatitis C: Comparison using ROC analysis
-
Walsh KM, Timms P, Campbell S, MacSween RN, Morris AJ. Plasma levels of matrix metalloproteinase-2 (MMP2) and tissue inhibitors of metalloproteinases -1 and -2 (TIMP-I and TIMP-2) as noninvasive markers of liver disease in chronic hepatitis C: comparison using ROC analysis. Dig Dis Sei 1999;44:624-630
-
(1999)
Dig Dis Sei
, vol.44
, pp. 624-630
-
-
Walsh, K.M.1
Timms, P.2
Campbell, S.3
MacSween, R.N.4
Morris, A.J.5
-
35
-
-
0035119323
-
Matrix metalloproteinase (MMP)-2, MMP-7, and tissue inhibitor of metalloproteinase-1 are closely related to the fibroproliferative process in the liver during chronic hepatitis C
-
Lichtinghagen R, Michels D, Haberkorn CI, Arndt B, Bahr M, Flemming P. Matrix metalloproteinase (MMP)-2, MMP-7, and tissue inhibitor of metalloproteinase-1 are closely related to the fibroproliferative process in the liver during chronic hepatitis C. J Hepatol 2001;34:239-247
-
(2001)
J Hepatol
, vol.34
, pp. 239-247
-
-
Lichtinghagen, R.1
Michels, D.2
Haberkorn, C.I.3
Arndt, B.4
Bahr, M.5
Flemming, P.6
-
36
-
-
0036135242
-
Diagnostic potential of circulating TIMP-1 and MMP-2 as markers of liver fibrosis in patients with chronic hepatitis C
-
DOI 10.1016/S0009-8981(01)00730-6, PII S0009898101007306
-
Boeker KH, Habenkorn CI, Michels D, Flemming P, Manns MP, Lichtinghagen R. Diagnostic potential of circulating TIMP-I and MMP-2 as markers of liver fibrosis in patients with chronic hepatitis C. Clin Chim Acta 2002;316:71-81. (Pubitemid 34028190)
-
(2002)
Clinica Chimica Acta
, vol.316
, Issue.1-2
, pp. 71-81
-
-
Boeker, K.H.1
Haberkorn, C.I.2
Michels, D.3
Flemming, P.4
Manns, M.P.5
Lichtinghagen, R.6
-
37
-
-
33846846344
-
Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B
-
Sebastiani G, Vario A, Guido M, Alberti A. Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B. World J Gastroenterol 2007;13:52531.
-
(2007)
World J Gastroenterol
, vol.13
, pp. 52531
-
-
Sebastiani, G.1
Vario, A.2
Guido, M.3
Alberti, A.4
-
38
-
-
44849126116
-
Retrospective evaluation of serum markers APRI and AST/ALT for assessing liver fibrosis and cirrhosis in chronic hepatitis B and C patients with hepatocellular carcinoma
-
Lin CS, Chang CS, Yang SS, Yeh HZ, Lin CW. Retrospective evaluation of serum markers APRI and AST/ALT for assessing liver fibrosis and cirrhosis in chronic hepatitis B and C patients with hepatocellular carcinoma. Inter Med 2008;47:569-575
-
(2008)
Inter Med
, vol.47
, pp. 569-575
-
-
Lin, C.S.1
Chang, C.S.2
Yang, S.S.3
Yeh, H.Z.4
Lin, C.W.5
-
39
-
-
0035082529
-
Expression of cyclooxygenase-2 promotes the release of matrix metalloproteinase-2 and -9 in fetal rat hepatocytes
-
Callejas NA, Casado M, Diaz-Guerra MJ, Boscà L, Martin-Sanz P. Expression of cyclooxygenase-2 promotes the release of matrix metalloproteinase-2 and -9 in fetal rat hepatocytes. Hepatology 2001;33:86086.
-
(2001)
Hepatology
, vol.33
, pp. 86086
-
-
Callejas, N.A.1
Casado, M.2
Diaz-Guerra, M.J.3
Boscà, L.4
Martin-Sanz, P.5
-
40
-
-
0031454180
-
Serum levels of tissue inhibitor of metalloproteinases-2 and of precursor form of matrix metalloproteinase-2 in patients with fiver disease
-
Ebata M, Fukuda Y, Nakano I, Katano Y, Fujimoto N, Hayakawa T. Serum levels of tissue inhibitor of metalloproteinases-2 and of precursor form of matrix metalloproteinase-2 in patients with fiver disease. Liver 1997;17:293-299
-
(1997)
Liver
, vol.17
, pp. 293-299
-
-
Ebata, M.1
Fukuda, Y.2
Nakano, I.3
Katano, Y.4
Fujimoto, N.5
Hayakawa, T.6
-
41
-
-
0031048395
-
Circulating matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as serum markers of fibrosis in patients with chronic hepatitis C
-
Relationship to interferon response.
-
Kasahara A, Hayashi N, Mochizuki K, Oshita M, Katayama K, Kato M et al. Circulating matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as serum markers of fibrosis in patients with chronic hepatitis C. Relationship to interferon response. J Hepatol 1997;26:574-583
-
(1997)
J Hepatol
, vol.26
, pp. 574-583
-
-
Kasahara, A.1
Hayashi, N.2
Mochizuki, K.3
Oshita, M.4
Katayama, K.5
Kato, M.6
-
42
-
-
0034934457
-
Diagnostic value of serum markers of connective tissue turnover for predicting histological staging and grading in patients with chronic hepatitis C
-
DOI 10.1007/s005350170084
-
Murawaki Y, Bcuta Y, OkamotoK, Koda M, Kawasaki H. Diagnostic value of serum markers of connective tissue turnover for predicting histological staging and grading in patients with chronic hepatitis C. J Gastroenterol 2001;36:399-406. (Pubitemid 32633448)
-
(2001)
Journal of Gastroenterology
, vol.36
, Issue.6
, pp. 399-406
-
-
Murawaki, Y.1
Ikuta, Y.2
Okamoto, K.3
Koda, M.4
Kawasaki, H.5
-
43
-
-
0033968058
-
Expression of matrix metalloproteinase-2 and -9 and their inhibitors in peripheral blood cells of patients with chronic hepatitis C
-
Lichtinghagen R, Huegel O, Seifert T, Haberkorn CI, Michels D, Flemming P et al Expression of matrix metalloproteinase-2 and -9 and their inhibitors in peripheral blood cells of patients with chronic hepatitis C. Clin Chem 2000;46:183-192
-
(2000)
Clin Chem
, vol.46
, pp. 183-192
-
-
Lichtinghagen, R.1
Huegel, O.2
Seifert, T.3
Haberkorn, C.I.4
Michels, D.5
Flemming, P.6
|